COVID-19 pandemic in the Lakshadweep Islands
DiseaseCOVID-19
Virus strainSARS-CoV-2
LocationLakshadweep Islands, India
First outbreakWuhan, Hubei, China
Arrival date18 January 2021
(3 years, 1 week and 1 day)
Confirmed cases10,297
Active cases5
Deaths
51

The first case of COVID-19 on the Union Territory of Lakshadweep was recorded on 18 January 2021.[1] Lakshadweep Islands, until then, was India's only COVID-free territory (state/UT), and life was fairly normal for the residents of the UT.[2] As of 13 September 2021, there were 10,297 confirmed cases (5 active) and 51 deaths.[3]

Timeline

COVID-19 vaccines with approval for emergency or conditional usage

Main article: COVID-19 vaccination in India

Two vaccines - University of Oxford’s AZD1222 (marketed as Covishield in India) and BBV152 (marketed as Covaxin, developed in India by Bharat Biotech in association with the ICMR and NIV) were approved by the Drug Controller General of India on 1st and 2nd January 2021.[5][6] Both can be stored, transpedorted and handled at normal refrigerated conditions (2-8 degrees Celsius).

See also

References

  1. ^ "Nearly a year after Covid-19 outbreak in India, Lakshadweep reports its first-ever case". India Today. Retrieved 22 January 2021.
  2. ^ "What Covid-19? Life is normal is Lakshadweep". Times of India. 9 December 2020. Retrieved 22 January 2021.
  3. ^ a b c d e f "MoHFW-Home". www.mohfw.gov.in. Retrieved 22 January 2021.
  4. ^ "Lakshadweep administration imposes travel restriction to mainland in view of rising COVID-19 cases in Kerala". The Hindu. PTI. 13 August 2021. ISSN 0971-751X. Retrieved 17 August 2021.((cite news)): CS1 maint: others (link)
  5. ^ "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 22 January 2021.
  6. ^ "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 22 January 2021.